1
|
Modugno F and Edwards RP: Ovarian cancer:
prevention, detection, and treatment of the disease and its
recurrence. Molecular mechanisms and personalized medicine meeting
report. Int J Gynecol Cancer. 22:S45–S57. 2012. View Article : Google Scholar
|
2
|
Ali AY, Farrand L, Kim JY, et al:
Molecular determinants of ovarian cancer chemoresistance: new
insights into an old conundrum. Ann N Y Acad Sci. 1271:58–67. 2012.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Okamura H and Katabuchi H:
Pathophysiological dynamics of human ovarian surface epithelial
cells in epithelial ovarian carcinogenesis. Int Rev Cytol.
242:1–54. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Yu H, Kortylewski M and Pardoll D:
Crosstalk between cancer and immune cells: role of STAT3 in the
tumour microenvironment. Nat Rev Immunol. 7:41–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: a leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Page BD, Ball DP and Gunning PT: Signal
transducer and activator of transcription 3 inhibitors: a patent
review. Expert Opin Ther Pat. 21:65–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Tseng LM, Huang PI, Chen YR, et al:
Targeting signal transducer and activator of transcription 3
pathway by cucurbitacin I diminishes self-renewing and
radiochemoresistant abilities in thyroid cancer-derived CD133+
cells. J Pharmacol Exp Ther. 341:410–423. 2012.PubMed/NCBI
|
8
|
Zhang X, Liu P, Zhang B, Wang A and Yang
M: Role of STAT3 decoy oligodeoxynucleotides on cell invasion and
chemosensitivity in human epithelial ovarian cancer cells. Cancer
Genet Cytogenet. 197:46–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Fujiwara Y, Komohara Y, Ikeda T and Takeya
M: Corosolic acid inhibits glioblastoma cell proliferation by
suppressing the activation of signal transducer and activator of
transcription-3 and nuclear factor-kappa B in tumor cells and
tumor-associated macrophages. Cancer Sci. 102:206–211. 2011.
View Article : Google Scholar
|
10
|
Horlad H, Fujiwara Y, Takemura K, et al:
Corosolic acid impairs tumor development and lung metastasis by
inhibiting the immunosuppressive activity of myeloid-derived
suppressor cells. Mol Nutr Food Res. 57:1046–1054. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Komohara Y, Ohnishi K, Kuratsu J and
Takeya M: Possible involvement of the M2 anti-inflammatory
macrophage phenotype in growth of human gliomas. J Pathol.
216:15–24. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Takaishi K, Komohara Y, Tashiro H, et al:
Involvement of M2-polarized macrophages in the ascites from
advanced epithelial ovarian carcinoma in tumor progression via
Stat3 activation. Cancer Sci. 101:2128–2136. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kawamura K, Komohara Y, Takaishi K,
Katabuchi H and Takeya M: Detection of M2 macrophages and
colony-stimulating factor 1 expression in serous and mucinous
ovarian epithelial tumors. Pathol Int. 59:300–305. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
16
|
Sica A, Larghi P, Mancino A, et al:
Macrophage polarization in tumour progression. Semin Cancer Biol.
18:349–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Komohara Y, Horlad H, Ohnishi K, et al: M2
macrophage/microglial cells induce activation of Stat3 in primary
central nervous system lymphoma. J Clin Exp Hematop. 51:93–99.
2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Komohara Y, Horlad H, Ohnishi K, et al:
Importance of direct macrophage-tumor cell interaction on
progression of human glioma. Cancer Sci. 103:2465–2172. 2012.
View Article : Google Scholar : PubMed/NCBI
|